Note: Ingredients listed on restricted chemical lists
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
≥25-≤50
EC/CAS
64742-82-1
Name of the chemical
Naphtha (petroleum), hydrodesulfurized heavy
Concentration
<1
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≤1
EC/CAS
64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
≤0.3
EC/CAS
64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
≤0.3
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
≤0.3
General Information
Version
13.01
Revision date
2025-10-18
Product name
Hi-Solids Polyurethane 250- Semi-Gloss (Part S) FS 10075
Manufacturer Name
THE SHERWIN-WILLIAMS COMPANY
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
Company name
THE SHERWIN-WILLIAMS COMPANY
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H226, H317, H336, H350, H361, H372
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
27.2% (oral), 27.2% (dermal), 27.2% (inhalation)
Signal word
Danger
Hazard statements
Flammable liquid and vapor. May cause an allergic skin reaction. May cause drowsiness or dizziness. May cause cancer. Suspected of damaging fertility or the unborn child. Causes damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Use only outdoors or in a well-ventilated area. Do not breathe vapor. Do not eat, drink or smoke when using this product. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace.
Response
IF exposed or concerned Get medical advice or attention. IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. If skin irritation or rash occurs: Get medical advice or attention.
Storage
Store locked up. Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Contains solvents which can cause permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. WARNING: This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. FOR INDUSTRIAL USE ONLY. This product must be mixed with other components before use. Before opening the packages, READ AND FOLLOW WARNING LABELS ON ALL COMPONENTS. Adequate ventilation required when sanding or abrading the dried film. If Adequate ventilation cannot be provided wear an approved particulate respirator (NIOSH approved). Follow respirator manufacturer's directions for respirator use. DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Abrading or sanding of the dry film may release Crystalline Silica which has been shown to cause lung damage and cancer under long term exposure. Please refer to the SDS for additional information. Keep out of reach of children. Do not transfer contents to other containers for storage.
2.3 Other hazards
None known. Hazards identified when used : No known significant effects or critical hazards.
2.1 Classification of the substance or mixture
SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 1A TOXIC TO REPRODUCTION - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 27.2% (oral), 27.2% (dermal), 27.2% (inhalation)